Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline.

Slides:



Advertisements
Similar presentations
Methods of tablet manufacturing
Advertisements

Satish Mallya January 20-22, |1 | 3-1. Assessing Batch Records Satish Mallya Quality Workshop, Copenhagen May 18-21,2014 May 18-21,2014.
Nordson Europe 3rd Generation Powder Coating Equipment
Manufacturing Process
World Health Organization
Determine impurity level in relevant batches1
Pharmtech Contract Services Offered by the Division of Pharmaceutical Technology.
Drying in the Pharmaceutical Industry1 DIT- Msc Pharmaceutical and Chemical Processes Technologies 28 th April 2009 Sara Baeza.
Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.
CHE 185 – PROCESS CONTROL AND DYNAMICS CONTROL LOOP ANALYSIS.
Ray Scherzer FDA ACPS October 26, 2005 Breaking with Tradition: The Manufacturing Challenges Ahead!
MIT PHARMACEUTICAL MANUFACTURING INITIATIVE (PHARMI) PHARMACEUTICAL MANUFACTURING: NEW TECHNOLOGY OPPORTUNITIES.. G.K.Raju, Ph.D. Executive Director, Pharmaceutical.
000ppt ATK Thiokol Propulsion A Collaborative Effort for Manufacturing and Testing of GEM Rocket Propellant Mike Rose, Connie Murphy and Rich Muscato Presented.
World Health Organization
PAT Validation Working Group Process and Analytical Validation Working Group Arthur H. Kibbe, Ph.D. Chair June 13, 2002.
Learnings from Pre-approval Joint Inspection of a GSK QbD Product with US-FDA & EMA and the application of Continuous Verification 17 May 2011, Beijing,
Condition Monitoring Adam Adgar School of Computing and Technology.
A Seminar on 1.  Why to validate?  Parts of Equipment Validation  Who should do Equipment Validation?  Equipment qualification  Typical process flow.
Computer Process Control Application. Computer process control In computer process control, a digital computer is used to direct the operations of a manufacturing.
Total Quality Management System (TQMS) AstraZeneca Solid Dosage Facility, Plankstadt, Germany Ali Afnan AstraZeneca Pharmaceuticals Engineering Group Alderley.
FDA Regulatory Perspective on Continuous Manufacturing
Applications and benefits of PAT Steve Hammond Global Manufacturing Services Process Analytical Support Group Sandwich, UK.
Helping the World Be Well through Innovative Manufacturing
University of Medicine and Pharmacy „Iuliu Haţieganu”, Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, , Cluj-Napoca,
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Bob Chisholm TQMS STATISTICALLY BASED IN-PROCESS CONTROL WITH REAL TIME QUALITY ASSURANCE The AstraZeneca Total Quality Management Strategy R S Chisholm.
DEVELOPMENT OF QUALITY BY DESIGN (QBD) GUIDANCE ELEMENTS ON DESIGN SPACE SPECIFICATIONS ACROSS SCALES WITH STABILITY CONSIDERATIONS Fluid Bed Drying Small.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
NIPTE-FDA Collaborative Case Study On Model-based Design Space Development Across Scales & with Stability Considerations Preliminary Design Space 1.
DRAFT INFLUENCE OF PHYSICS OF TABLET COMPRESSION Small-Scale Presenter: Alberto Cuitino November 3 rd, 2010.
Evaluating a Research Report
1 Unit 1 Information for management. 2 Introduction Decision-making is the primary role of the management function. The manager’s decision will depend.
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
 Siemens Nederland N.V FDA13April Presented by Troy Logan at the Advisory Committee for Pharmaceutical Science meeting on April 13, 2004.
OBTAINING QUALITY MILL PERFORMANCE Dan Miller
Testing and Quality Control of Plastics Materials and Products ALOK KUMAR.
DEVELOPMENT OF QUALITY BY DESIGN (QBD) GUIDANCE ELEMENTS ON DESIGN SPACE SPECIFICATIONS ACROSS SCALES WITH STABILITY CONSIDERATIONS Blending Benoit Igne,
DEVELOPMENT OF QUALITY BY DESIGN (QBD) GUIDANCE ELEMENTS ON DESIGN SPACE SPECIFICATIONS ACROSS SCALES WITH STABILITY CONSIDERATIONS Scale-up Experimentation.
Critical Material Properties for Pharmaceutical Dosage Forms - Industry Perspective Tony Hlinak Abbott Laboratories North Chicago, IL.
Small molecules Liquids – Solvent composition – Reactions – HME Dry Powder – Blending – Dry Granulation – Dry milling Wet solids – API Crystallization.
MAKE OR BUY DECESION FOR FILM COATING MATERIAL 1. Consistency In ColourIn Colour a.Advanced colour matching system. Once a shade is produced It is stored.
From Design of Experiments to closed loop control
Some Future Developments Brian Carlin, Ph.D FMC Chris Moreton, Ph.D FinnBrit Consulting IPEC-Americas FDA Seminar, October 21,
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
FDA PROCESS ANALYTICAL TECHNOLOGY SUB COMMITTEE MEETING 25 TH FEBRUARY 2002 PERSPECTIVE ON PROCESS AND ANALYTICAL VALIDATION Robert S Chisholm.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
A Bayesian approach to the Comparison of NIR vs HPLC analytical methods in Continuous Manufacturing Process Validation Studies Areti Manola1, Jyh-Ming.
18.1 Introduction Powder metallurgy is a process by which fine powdered materials are blended, pressed into a desired shape, and then heated to bond.
Industrial Pharmacy I Mixing Milling Drying Filtration Preformulation Reference Theory and practice of Industrial Pharmacy Lachman.
Process Analytical Technology: An Industry Perspective John G. Shabushnig, Ph.D. Pharmacia Corporation February 25, 2002.
GRANULATION DR. MOHAMMAD KHALID ANWER Assistant Professor 2/25/20161 COLLEGE OF PHARMACY, PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY.
开发报批美国 FDA 的仿制药 与相关问题探讨 上海复星普适医药科技有限公司何平. 内容提要 开发仿制药的重要性和机遇 开发仿制药的重要性和机遇 开发仿制药的挑战 开发仿制药的挑战 申报仿制药的分类 申报仿制药的分类 仿制药研发团队 仿制药研发团队 仿制药的研发过程 仿制药的研发过程 QbD 在制剂开发中怎么体现.
QbD Technologies: Workshop for Risks Management Incorporating Risk Management for Technology Transfer.
Milling Is the reduction in the size mass by conversion of the large solid unit mass into smaller one by mechanical process. This needs energy.
Chapter 1: The Nature of Analytical Chemistry
Product & Process Working Group February 26, 2002.
Chemical Engineering Department Government Engineering College
TABLET GRANULATION TECHNIQUES.
Veego Instruments Corporation. 35 years successful years.
Methods of tablet manufacturing
© G.K.Raju, Ph.D. Manufacturing Science Sept 17th 2003 QUALITY BY DESIGN: The Means To Fundamental Manufacturing Science G.K.Raju, Ph.D.
Don State Technical University Department “Machine Building" 7/6/2016.
PROCESS ANALYTICAL TECHNOLOGY – A REVIEW By Mr. Akash Mali DEPARTMENT OF PHARMACEUTICS, G.I.P.E.R., LIMB, SATARA. 1.
Fundamentals of Analytical Chemistry Eighth Edition.
HOLD-TIME STUDIES.
Enabling direct compaction at high drug loading via dry coating of APIs: Towards a predictive framework Presenter(s): Kuriakose T. Kunnath, NJIT Research.
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
HHV 5014 Nutraceutical formulation technology
RingCap Technology Mrs. Maria Saifee Associate Professor,
Mageleka MagnoMeter™ XRS
Presentation transcript:

Process Analytical Technologies Subcommittee Product and Process Development: An Industry Perspective David Rudd PhD Process Technology GlaxoSmithKline Research and Development, UK

2 Source: UK Department of Trade and Industry UK manufacturing profitability by sector (1995 to 1999)

3 Manufacturing process Process feed Process output Store or hold Current manufacturing philosophy

4 Manufacturing process Process control Process feed Process output Closed loop control (process parameters only) Store or hold Temperature Time Pressure etc. Current control philosophy

5 Manufacturing process Policing function Off-line (lab-based) review of product quality parameters Process control Process feed Process output Closed loop control (process parameters only) Store or hold Temperature Time Pressure etc. Current control philosophy

6 Guaranteed product quality Avoidance of delay Optimal utilization of resource Minimization or elimination of waste Movement towards continuous processing Business case for improvement

7 Optimized process Scaleable process Ease of technology transfer Well-characterized (well-understood) process Reliable and robust process Product and process development objectives

8 Provision of manufacturing and monitoring equipment and technical expertise Development of process understanding Identification of critical process parameters Implementation of critical process controls Decision-making basis for process feedback R&D responsibilities - in conjunction with Manufacturing

9 Tablet manufacturing process Dispensing and sieving Dispensing and sieving Blending Blending Granulation and milling Granulation and milling Drying Drying Compression Compression Film coating Film coating

10 Homogeneity of powder blend (on-line NIR, at-line HPLC or UV-visible and/or imaging techniques) Homogeneity of powder blend (on-line NIR, at-line HPLC or UV-visible and/or imaging techniques) Moisture content (on- line near infra-red and/or ERH probes) Moisture content (on- line near infra-red and/or ERH probes) Blending

11 Concentration of analyte versus time Near infra-red monitoring of powder blend process

12 Replication of spectra (moving block of 12 samples) Near infra-red monitoring of powder blend process

13 Powder blend imaging using spectroscopy

14 Powder blend dynamics

15 Granulation end-point Granulation end-point Flow characteristics, bulk density etc Flow characteristics, bulk density etc Homegeneity of granule Homegeneity of granule Moisture content Moisture content Particle size Particle size Granulation and milling

16 Power consumption curve during granulation

Karl Fischer value (%w/w) NIR predicted Particle size (sieve analysis) in microns NIR predicted Near infra-red monitoring of granulation process

Acoustic monitoring of high shear granulation process

Machine off Dry mixing Wet massing Liquid addition (wet granulation) Acoustic emission produced during granulation process

20 Actual versus predicted Mass Median particle size

21 Actual versus predicted Flowability Index

22 Actual versus predicted maximum crushing strength

23 Effect of scale on acoustic signature of a granulation process

24 Stages of the product manufacturing process can be characterized and then described based on the use of a variety of diverse measurement techniques This multi-dimensional profile can then be used to produce a process ‘signature’ which, in turn, offers a means of ensuring process reproducibility and robustness The process ‘signature’ may also be viewed as an end-point to work towards during scale-up or after equipment changes or site changes, for example Process ‘signature’

25 Perhaps the concept of the process ‘signature’ equates to the establishment of a process specification - that is, a series of requirements which need to be met if the process is to be considered ‘under control’? Just as parametric release implies the removal of critical end-product testing, perhaps the natural corollary is to transfer the critical specification from the product to the process? Process specification

26 Manufacturing process Control function On-line monitoring of critical process parameters Process control Process feed Process output Closed loop control (process parameters only) Temperature Time Pressure etc. Future control philosophy

27 To Granulator Continuous dry blender Mass flow Excipient A Mass flow Excipient B Mass flow Active Mass flow PAT Blend speed Control philosophy PAT (NIR, process imaging etc) monitors composition and blend uniformity Feedback controls mass flow in or out and modifies blend speed, if necessary Key Mass flow control Instrumentation Material flow Process control loop Physical control loop Continuous blending process

28 Development of novel analytical monitoring techniques (or novel applications of existing techniques) appropriate for the type of measurements required Emphasis on indicators of ‘change’ rather than necessarily quantitative measurement New data processing methods required (data reduction and/or combinations of data from diverse sources) Implications and new research areas

29 Development scale = Manufacturing scale? Establish relationship between traditional end-product quality parameters (release and end-of-life specification for finished product) and key process measurements Demonstrate predictive capability of in- process measurements Development of process specification Implications during product and process development

30 Process Analytical Technology (PAT) is seen as a means of improving existing manufacturing process monitoring and control strategies The most significant advantages are to be gained by moving towards true process understanding (gained during process development) which, in turn, offers the opportunity of ‘Quality by Design’ manufacturing methods and parametric release concepts PAT is vital if the pharmaceutical manufacturing industry is ever to embrace continuous processing Final thoughts